Quality of Life and Illness Costs in Irritable Bowel Syndrome
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
The burden of selected digestive diseases in the United States
Sandler, R. S., Everhart, J. E., Donowitz, M., Adams, E., Cronin, K., Goodman, C., Gemmen, E., Shah, S., Avdic, A., & Rubin, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32978 · Cited by 1,512
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761 · cited 1×
“the IBS-Quality of Life Measure (IBS-QOL) by Patrick et al. [”
MethodAgréus, L., Svärdsudd, K., Nyrén, O., & Tibblin, G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90373-9 · Cited by 686
Design of Treatment Trials for Functional Gastrointestinal Disorders
Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.010 · Cited by 550
Medical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460 · cited 1×
“reported on the burden of 17 selected digestive diseases in the United States. IBS was one of the diseases included in the analysis. The yearly direct cost for IBS was calculated as USD 1.3 billion, where hospital inpatient services accounted for the majority of these costs. This can be compared with a previous study…”
ResultInfluentialPredictors of health care seeking for irritable bowel syndrome: a population based study
Talley, N. J., Boyce, P. M., & Jones, M. (1997) · Gut · doi:10.1136/gut.41.3.394 · Cited by 250
Mearin, X. B. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520152584770 · Cited by 240
Validation of a specific quality of life questionnaire for functional digestive disorders
Chassany, O., Marquis, P., Scherrer, B., Read, N. W., Finger, T., Bergmann, J. F., Fraitag, B., Geneve, J., & Caulin, C. (1999) · Gut · doi:10.1136/gut.44.4.527 · Cited by 180 · cited 1×
“and the Functional Digestive Disorders Quality of Life Questionnaire [”
Background
Cited by
Review article: the economic impact of the irritable bowel syndrome
Canavan, C., West, J., & Card, T. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12938 · Cited by 458
“Costs from a third-party payer perspective are those most easily available and most widely analysed.(3) Finally, there is the cost to soci-”
BackgroundThe economic impact of irritable bowel syndrome
Inadomi, J. M., Fennerty, M. B., & Bjorkman, D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.t01-1-01736.x · Cited by 190
Jerndal, P., Ringström, G., Agerforz, P., Karpefors, M., Akkermans, L. M., Bayati, A., & Simrén, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01493.x · Cited by 192
Self-citationLindfors, P., Unge, P., Arvidsson, P., Nyhlin, H., Björnsson, E., Abrahamsson, H., & Simrén, M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.340 · Cited by 138
“Some of the patients have severe, intrusive symptoms refractory to current conventional treatment options, leading to substantial reduction in quality of life (QOL) and on psychological well-being (”
BackgroundSelf-citationPeripheral factors in the pathophysiology of irritable bowel syndrome
Gunnarsson, J., & Simrén, M. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.006 · Cited by 57
Self-citation
Metadata
- Authors
- Simrén, M., Brazier, J., Coremans, G., Dapoigny, M., Müller-Lissner, S. A., Pace, F., Smout, A. J. P. M., Stockbrügger, R. W., Vatn, M. H., & Whorwell, P. J.
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 69
- Issue
- 4
- Pages
- 254-261
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2112500205
- Cited by
- 39
- References
- 10
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.